Bovine Serum Albumin Market Size, Share, and Analysis By Grade (Technical and Diagnostic Grade, Research/Reagent Grade, and Food Grade), By End-user (Life Science Industry, Food Industry, Research Institutes, and Others), By Application (In Vitro Diagnostics, Vaccine Production, Biochemical Assay, and Others), and Regional Forecast, 2024-2032

Bovine serum albumin is a protein derived from the bovine blood plasma, which is a stable, small, and moderately non-reactive protein. It is the main constituent of the Fetal Bovine Serum (FBS), used as a protein concentration standard in the laboratory. The increasing application of the product in animal breeding, marine biotechnology, chemicals and enzymes, and food & beverages industries is likely to drive the bovine serum albumin market growth.

An increasing prevalence of chronic medical ailments forms one of the major drivers surging the demand for bovine serum albumin. Albumin has the ability to inhibit tumor-causing factors and binds to fat to mobilize them in the body to perform functions such as obtaining energy or forming membranes. Bovine Serum Albumin (BSA) also blocks the conversion of angiotensin I into angiotensin II (vasoconstrictor), giving it antihypertensive action. For instance, in April 2022, Apotex Corp., a Canadian pharmaceutical corporation, launched a Generic of Abraxane in the U.S. The company launched Paclitaxel protein-bound particles for injection (albumin-bound), which helps treat metastatic breast cancer and adenocarcinoma of the pancreas.

Impact of COVID-19 on the Global Bovine Serum Albumin Market

The COVID-19 pandemic has majorly impacted the healthcare sector. The pandemic positively impacted the global bovine serum albumin market, owing to the increase in the use of bovine albumins to produce vaccines, such as Covaxin and Covishield, for treating COVID-19 infection, thus resulting in increased demand for bovine serum albumin. However, there was a negative impact on the supply chain, development, and production of reagents such as bovine serum albumin, which affected businesses of various healthcare sectors.

Key Insights

The report will cover the following key insights:

• Parent market overview


• Macro-economic factors


• COVID-19 impact on the bovine serum albumin market


• Industry growth and impact


• Porter's five forces analysis


• Industry dynamics – drivers, restraints, and opportunities


• Market trends, recent developments, and new product launch


• Market sizing, estimation, forecasting, and growth prospects


• Regional analysis

Analysis by Grade

Based on grade, the market is segmented into technical and diagnostic grade, research/reagent grade, and food grade. The technical and diagnostic grade segment is expected to account for a major bovine serum albumin market share. BSA is used for sensitive immunoassays, immunohistochemistry, immunoblots, and stabilizing agents for protein reagents. Furthermore, bovine serum albumin is also used as an additive for hybridoma cell culture, serum-free cell culture, and as a blocking agent.

Analysis by End-user

Based on end-user, the market is segmented into life science industry, food industry, research institutes, others. The life sciences industry segment is expected to have a significant share of the global bovine serum albumin market over the forecast period. The life science industry operates in biotechnology, nutraceuticals, cosmeceuticals, pharmaceuticals, and other fields for improving human healthcare. Several players adopt strategies to meet the demands from the global healthcare markets. For instance, in July 2022, Pristine Biologicals, a subsidiary of Indian Immunologicals Ltd, inaugurated a new facility in Dargaville for the production of sterile filtered serum. The requirement for bovine serum is increasing to manufacture the biologics, which led the company to invest overseas. The company has also planned to double the capacity as soon as the demand rises, which helped to produce more quantity of the serum.

Analysis by Application

Based on application, the market is segmented into in vitro diagnostics, vaccine production, biochemical assay, and others. Over the forecast period, the in-vitro diagnostics segment is expected to account for a significant market share. In-vitro diagnostics are the tests that help to detect infections and diseases. These tests can be performed on various instruments, which range from small, handheld tests to complex laboratory instruments. These factors augment the growth of the bovine serum albumin market.

Analysis by Region

To gain extensive insights into the market, Request for Customization

North America is expected to hold a significant bovine serum albumin market share due to the developing in-vitro diagnostics market in the region. Bovine serum albumin is used as a reagent in various microbiology applications, immunology, immunochemistry, hematology, and clinical chemistry. According to the Centers of Disease Control and Prevention report published in July 2022, six in ten Americans have at least one chronic disease such as stroke, heart disease, cancer, or diabetes. The rise in the cases of chronic illness within the region and the growth in demand for personalized medicines are expected to fuel the demand for bovine serum albumin in the region.

Key Market Players

Major players include Thermo Fisher Scientific, Merck Group, Nucleus Biologics, Proliant Biologicals, Bio-Rad Laboratories, Inc., BelHealth investment partners, LLC., Biological Industries, Rockland Immunochemicals Inc, Promega Corporation, and Serion GmbH.

Segmentation

Key Industry Development

In February 2019, Proliant Biologicals, a manufacturer of protein ingredients for food, health, nutrition, and biologicals, launched a new line of bovine serum albumin solutions. The new product includes ‘Ultra-high Monomer’ bovine serum albumin solutions and standard 30% bovine serum albumin solutions.